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Background 
Patients with metastatic spinal tumours 
have a poor prognosis. Surgery is often 
palliative and aims to relieve debilitating 
symptoms of pain, incontinence and 
paralysis1.  Achieving successful wound 
healing after surgery is challenging 
because patients are often malnourished, 
catabolic and immunosuppressed.  
Surgical site infection (SSI) is therefore 
more common in these patients than 
those undergoing non-tumour spinal 
surgery.  The onset of SSI can, in severe 
cases, result in the removal of spinal 
instrumentation implanted specifically to 
stabilise the spine, ultimately leading to 
surgical failure. However, the degree to 
which SSI impacts on mortality is 
unknown. 
 
 
Aim 
• To assess the impact of SSI on 
patient survival after surgery for 
spinal metastases. 
 
 
Methods 
Patients who had previously undergone 
surgery for treatment of metastatic spinal 
tumours at Salford Royal NHS Foundation 
Trust between 1st January 2009 and 31st 
December 2012 were identified through 
the hospital electronic patient record.  The 
following data were collected: 
• Demographics 
• Operative details 
• American Society of Anesthesiologists 
(ASA) grade 
• Revised Tokuhashi Score (RTS) 
• Patient survival (final follow up as of 15th 
July 2014) 
• Occurrence of infection (according to 
Public Health England criteria) 
 
 
A semi-parametric Cox proportional 
hazards survival analysis was used to 
assess the relationships between 
covariates and survival.  Assumptions for 
the analysis were checked in exploratory 
procedures. 
Results 
A total of 152 patients (77 females and 75 
males) underwent surgery for spinal 
metastases over the four year study period.  
Mean age at operation was 60.5 years (SD 
12.9 years). Seventeen patients (11.2%) 
experienced SSI. At the time of last follow 
up, 117 patients had died. The assumption 
of proportional hazards was found to be 
tenable, and measures of patient fitness 
were not excessively correlated. Survival 
curves using ASA and RTS scores are 
shown in Figures 1 and 2. 
 
Overall, median survival time from operation 
was 262 days (95% CI: 190 - 334 days): 
 
  SSI: 135 days (95% CI: 62 – 208 days) 
 
  Non-SSI: 276 days (95% CI: 183 – 369 days) Discussion 
SSI is the most common complication of 
surgery for spinal metastases1. SSI rates 
are higher in this group of patients than in 
those undergoing non-tumour spinal 
surgery2. This study provides some 
evidence to suggest that those without 
SSI may survive longer than those with 
infection, though this result may require 
further confirmation. Both ASA grade and 
RTS appear to be useful in predicting 
survival, with better survival found in 
patients with higher RTS and lower ASA 
scores. 
 
Conclusions 
Five-year survival in patients undergoing 
surgery for spinal metastases is 
approximately 23%. Either or both of RTS 
or ASA scores can be used as indicators 
of patient survival. There is currently 
insufficient evidence to conclude that the 
presence of SSI retards survival. 
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Figure 1.  Survival curves for patients with low (≤ 2) 
and high (≥ 3) ASA scores. 
 
 
Figure 2. Survival curves with low (1-5), medium (6-10) 
and high (11-15) RTS scores. 
 
 
A Cox multiple regression model showed 
both ASA and RTS scores to be 
significantly associated with patient 
survival  (Table 1). Each additional point 
on the ASA scale is associated with a 37% 
raised hazard of death (p=0.028). Each 
additional point on the RTS scale is 
associated with an 18% lowered hazard of 
death (p<0.001). 
 
Infection status was of substantive 
importance, with better survival in 
those without SSI (p=0.075). 
 
Age was not substantively related to 
survival (p=0.299). 
Table 1.  Associations of ASA grade and RTS with patient 
survival. 
 
 
 
Variable 
 
Parameter 
estimate 
 
p-
value 
 
Hazard 
ratio 
 
95% CI for hazard ratio 
Lower Upper 
ASA score 0.316 0.028 1.371 1.034 1.819 
RTS score -0.195 <0.001 0.823 0.762 0.889 
 
